SCHEMBL84474

SCHEMBL84474

CCC(C)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30685216 1.00
SCHEMBL13020450 1.00
SCHEMBL13165952 1.00
Ammonia Solution, Strong SCHEMBL8474755 0.95
SCHEMBL9997340 0.84 TSHR (0.33)
SCHEMBL25953 0.80
SCHEMBL477890 0.80
SCHEMBL477963 0.80
SCHEMBL28809271 0.79 TSHR (0.30)
SCHEMBL1682618 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 909 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101920-A1 IMPROVED FLASH SPINNING PROCESS FOR POLYOLEFINS USING FLASH SPINNING AGENTS COMPRISING A MONOFLUOROHYDROCARBON WITH 4 OR 5 CARBON ATOMS DUPONT SAFETY & CONSTRUCTION, INC. (US) 2026-05-15 WO claimed
CN-113429378-B 1, 3-propane sultone methyl fluoro derivative and preparation method and application thereof 武汉松石科技股份有限公司 2022-09-02 CN claimed
US-11046699-B2 Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses RAPT THERAPEUTICS, INC. (US) 2021-06-29 US claimed
CN-105873631-B Device and method for continuous drug delivery via the oral cavity 辛纳吉勒公司 2021-06-18 CN claimed
EP-3802544-A1 PYRAZOLO-PYRIMIDIN-AMINO-CYCLOALKYL COMPOUNDS AND THEIR THERAPEUTIC USES RAPT Therapeutics, Inc. (US) 2021-04-14 EP claimed
US-10786474-B2 Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use SYNAGILE CORPORATION (US) 2020-09-29 US claimed
US-20200215012-A1 PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE SYNAGILE CORPORATION 2020-07-09 US claimed
US-10647642-B2 Method for producing fluorinated hydrocarbons ZEON CORPORATION (JP) 2020-05-12 US claimed
CN-111048841-A Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery using same 三菱化学株式会社 2020-04-21 CN claimed
EP-3604262-A1 PRODUCTION METHOD FOR FLUORINATED HYDROCARBON Zeon Corporation (JP) 2020-02-05 EP claimed
WO-2004058829-A1 POLYMERIZATION PROCESSES EXXONMOBIL CHEMICAL PATENTS, INC. (US) 2004-07-15 WO claimed
WO-2004058836-A1 POLYMERS WITH NEW SEQUENCE DISTRIBUTIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-07-15 WO claimed
WO-2004058825-A2 POLYMERS WITH NEW SEQUENCE DISTRIBUTIONS EXXONMOBIL CHEMICAL PATENTS, INC. (US) 2004-07-15 WO claimed
WO-2004058828-A1 POLYMERIZATION PROCESSES EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-07-15 WO claimed
WO-2004058827-A1 POLYMERIZATION PROCESSES EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-07-15 WO claimed
WO-2001080839-A2 USE OF NAPHTHINDAZOLE-4,9-QUINONES AS ANTIPARASITIC AGENTS BUNDESREPUBLIK DEUTSCHLAND vertreten durch das BUNDESMINISTERIUM FÜR GESUNDHEIT, dieses vertreten durch das ROBERT-KOCH-INSTITUT, vertreten durch seinen leiter (DE) 2001-11-01 WO claimed
WO-2001080838-A2 USE OF N2-SUBSTITUTED BENZ[F]INDAZOLE-4,9-QUINONES AS ANTIPARASITIC AGENTS BUNDESREPUBLIK DEUTSCHLAND vertreten durch das BUNDESMINISTERIUM FÜR GESUNDHEIT, diesed vertreten durch das ROBERT-KOCH-INSTITUT, vertreten durch SEINEN LEITER (DE) 2001-11-01 WO claimed
US-5396022-A Defluorination of alkane streams PHILLIPS PETROLEUM COMPANY (US) 1995-03-07 US claimed
US-5206149-A Reaction of peroxidase, oxidant, luminol and 2-hydroxy-9-fluorenone enhancer; chemiluminescence TORAY INDUSTRIES, INC. (JP) 1993-04-27 US claimed
US-4049728-A PARAFFIN DILUENT, BY-PRODUCT INHIBITION PHILLIPS PETROLEUM COMPANY (US) 1977-09-20 US claimed